Metabolic Regulation Peptides Bioactive Toxin-Derived Peptides Tumor-Associated Antigen Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Neurodegenerative Disease Research Peptides Melanogenesis Modulation Anti-Aging & Skin Remodeling Gastrin, GRP & Bombesin Peptides Somatostatin Analogs DPPIV/CD26 Peptides Kinase Activity Modulators Caspase Substrates & Inhibitors Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Calcitonin & CGRP Family Peptides Incretin & Metabolic Peptides Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Peptide Coupling Reagents & Additives Specialty Peptide Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Neuromodulatory and Neuroactive Peptides Neurotransmitters/Neuropeptides [D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P | Potent SP Antagonist

DESCRIPTION

[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P is a full-length modified Substance P analog containing D-Arg1, D-Pro2, D-Trp7, D-Trp9 and Leu11 substitutions.

The peptide belongs to the early high-potency generation of Substance P antagonists and has been used to investigate tachykinin-dependent neural, vascular and smooth-muscle responses.

Product Information

Product Name[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P
Catalog No.AS2540
CAS No.84676-91-5
SequenceD-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2
Peptide Length11 residues
Molecular FormulaC75H108N20O13
Molecular WeightApproximately 1497.8 Da
Key ModificationsD-Arg1; D-Pro2; D-Trp7; D-Trp9; Leu11
Pharmacological ProfileClassical peptide Substance P antagonist

A High-Potency Early Substance P Antagonist

Comparative biological evaluation placed this peptide among the strongest undecapeptide antagonists of its generation. Reported pA2 values were approximately 7.1–7.2 in classical tissue preparations.

D-Pro2 distinguishes this analog from Spantide I, while the two peptides otherwise share D-Arg1, D-Trp7,9 and Leu11 substitutions.

Free Peptide Versus Acetate Salt CAS

The free peptide is associated with CAS 84676-91-5. CAS 143077-65-0 is used for the acetate salt and should not be substituted unless the supplied material is specifically identified as that salt form.

We recommend keeping salt form explicit in purchasing records and certificates because counterions can affect reported formula weight and peptide content calculations.

Research Applications

The peptide can support Substance P antagonist research, tachykinin functional assays, vascular and neural studies and comparative analysis of early peptide antagonist scaffolds.

Frequently Asked Questions

Is this peptide the same as Spantide I?

No. It contains an additional D-Pro substitution at position 2.

What CAS should be used for the free peptide?

CAS 84676-91-5. CAS 143077-65-0 refers to an acetate salt form.

Does it contain Met11?

No. Met11 is replaced by Leu.

Research Use Only.

[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P | Potent SP Antagonist

Catalog No: AS2540
Cas No: 84676-91-5

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit